162 related articles for article (PubMed ID: 10086392)
1. The absence of p53 accelerates atherosclerosis by increasing cell proliferation in vivo.
Guevara NV; Kim HS; Antonova EI; Chan L
Nat Med; 1999 Mar; 5(3):335-9. PubMed ID: 10086392
[TBL] [Abstract][Full Text] [Related]
2. Endogenous p53 protects vascular smooth muscle cells from apoptosis and reduces atherosclerosis in ApoE knockout mice.
Mercer J; Figg N; Stoneman V; Braganza D; Bennett MR
Circ Res; 2005 Apr; 96(6):667-74. PubMed ID: 15746445
[TBL] [Abstract][Full Text] [Related]
3. Absence of p21Waf1/Cip1/Sdi1 modulates macrophage differentiation and inflammatory response and protects against atherosclerosis.
Merched AJ; Chan L
Circulation; 2004 Dec; 110(25):3830-41. PubMed ID: 15596565
[TBL] [Abstract][Full Text] [Related]
4. Macrophage-specific p53 expression plays a crucial role in atherosclerosis development and plaque remodeling.
Merched AJ; Williams E; Chan L
Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1608-14. PubMed ID: 12842843
[TBL] [Abstract][Full Text] [Related]
5. Increased p53 gene dosage reduces neointimal thickening induced by mechanical injury but has no effect on native atherosclerosis.
Sanz-González SM; Barquín L; García-Cao I; Roque M; González JM; Fuster JJ; Castells MT; Flores JM; Serrano M; Andrés V
Cardiovasc Res; 2007 Sep; 75(4):803-12. PubMed ID: 17570351
[TBL] [Abstract][Full Text] [Related]
6. Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice.
Massy ZA; Ivanovski O; Nguyen-Khoa T; Angulo J; Szumilak D; Mothu N; Phan O; Daudon M; Lacour B; Drüeke TB; Muntzel MS
J Am Soc Nephrol; 2005 Jan; 16(1):109-16. PubMed ID: 15563564
[TBL] [Abstract][Full Text] [Related]
7. ApoE(-/-) mice develop atherosclerosis in the absence of complement component C5.
Patel S; Thelander EM; Hernandez M; Montenegro J; Hassing H; Burton C; Mundt S; Hermanowski-Vosatka A; Wright SD; Chao YS; Detmers PA
Biochem Biophys Res Commun; 2001 Aug; 286(1):164-70. PubMed ID: 11485323
[TBL] [Abstract][Full Text] [Related]
8. Genetic deletion of pregnancy-associated plasma protein-A is associated with resistance to atherosclerotic lesion development in apolipoprotein E-deficient mice challenged with a high-fat diet.
Harrington SC; Simari RD; Conover CA
Circ Res; 2007 Jun; 100(12):1696-702. PubMed ID: 17510462
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and/or a high-fat diet in a murine apolipoprotein E heterozygote model: pharmacotherapeutic implications.
Chi H; Messas E; Levine RA; Graves DT; Amar S
Circulation; 2004 Sep; 110(12):1678-85. PubMed ID: 15353494
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-alpha promotes atherosclerotic lesion progression in APOE*3-Leiden transgenic mice.
Boesten LS; Zadelaar AS; van Nieuwkoop A; Gijbels MJ; de Winther MP; Havekes LM; van Vlijmen BJ
Cardiovasc Res; 2005 Apr; 66(1):179-85. PubMed ID: 15769461
[TBL] [Abstract][Full Text] [Related]
11. The long-term effect of angiotensin II type 1a receptor deficiency on hypercholesterolemia-induced atherosclerosis.
Eto H; Miyata M; Shirasawa T; Akasaki Y; Hamada N; Nagaki A; Orihara K; Biro S; Tei C
Hypertens Res; 2008 Aug; 31(8):1631-42. PubMed ID: 18971539
[TBL] [Abstract][Full Text] [Related]
12. Endothelial overexpression of Fas ligand decreases atherosclerosis in apolipoprotein E-deficient mice.
Yang J; Sato K; Aprahamian T; Brown NJ; Hutcheson J; Bialik A; Perlman H; Walsh K
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1466-73. PubMed ID: 15178561
[TBL] [Abstract][Full Text] [Related]
13. Differential influence of chemokine receptors CCR2 and CXCR3 in development of atherosclerosis in vivo.
Veillard NR; Steffens S; Pelli G; Lu B; Kwak BR; Gerard C; Charo IF; Mach F
Circulation; 2005 Aug; 112(6):870-8. PubMed ID: 16061736
[TBL] [Abstract][Full Text] [Related]
14. Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice.
Kirii H; Niwa T; Yamada Y; Wada H; Saito K; Iwakura Y; Asano M; Moriwaki H; Seishima M
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):656-60. PubMed ID: 12615675
[TBL] [Abstract][Full Text] [Related]
15. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E promotes the regression of atherosclerosis independently of lowering plasma cholesterol levels.
Raffai RL; Loeb SM; Weisgraber KH
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):436-41. PubMed ID: 15591220
[TBL] [Abstract][Full Text] [Related]
17. Repopulation of apolipoprotein E knockout mice with CCR2-deficient bone marrow progenitor cells does not inhibit ongoing atherosclerotic lesion development.
Guo J; de Waard V; Van Eck M; Hildebrand RB; van Wanrooij EJ; Kuiper J; Maeda N; Benson GM; Groot PH; Van Berkel TJ
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1014-9. PubMed ID: 15774908
[TBL] [Abstract][Full Text] [Related]
18. Elimination of platelet factor 4 (PF4) from platelets reduces atherosclerosis in C57Bl/6 and apoE-/- mice.
Sachais BS; Turrentine T; Dawicki McKenna JM; Rux AH; Rader D; Kowalska MA
Thromb Haemost; 2007 Nov; 98(5):1108-13. PubMed ID: 18000617
[TBL] [Abstract][Full Text] [Related]
19. Genetic ablation of caveolin-1 confers protection against atherosclerosis.
Frank PG; Lee H; Park DS; Tandon NN; Scherer PE; Lisanti MP
Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):98-105. PubMed ID: 14563650
[TBL] [Abstract][Full Text] [Related]
20. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
